Allosteric Interactions between Adenosine A<sub>2A</sub> and Dopamine D<sub>2</sub> Receptors in Heteromeric Complexes: Biochemical and Pharmacological Characteristics, and Opportunities for PET Imaging

Allosteric Interactions between Adenosine A<sub>2A</sub> and Dopamine D<sub>2</sub> Receptors in Heteromeric Complexes: Biochemical and Pharmacological Characteristics, and Opportunities for PET Imaging

Adenosine and dopamine interact antagonistically in living mammals. These interactions are mediated via adenosine A<sub>2A</sub> and dopamine D<sub>2</sub> receptors (R). Stimulation of A<sub>2A</sub>R inhibits and blockade of A<sub>2A</sub>R enhances...

Full description

Bibliographic Details
Main Authors:	Kavya Prasad, Erik F. J. de Vries, Philip H. Elsinga, Rudi A. J. O. Dierckx, Aren van Waarde
Format:	Article
Language:	English
Published:	MDPI AG 2021-02-01
Series:	International Journal of Molecular Sciences
Subjects:	adenosine A<sub>2A</sub> receptor dopamine D<sub>2</sub> receptor heteromers allosteric interaction receptor–receptor interactions striatum
Online Access:	https://www.mdpi.com/1422-0067/22/4/1719

Similar Items

Allosteric Antagonism of the A<sub>2A</sub> Adenosine Receptor by a Series of Bitopic Ligands
by: Zhan-Guo Gao, et al.
Published: (2020-05-01)

Adenosine A<sub>2A</sub> Receptors Shut Down Adenosine A<sub>1</sub> Receptor-Mediated Presynaptic Inhibition to Promote Implementation of Hippocampal Long-Term Potentiation
by: Cátia R. Lopes, et al.
Published: (2023-04-01)

Allosteric Modulation of Adenosine A<sub>2A</sub> Receptors as a New Therapeutic Avenue
by: Mustafa Korkutata, et al.
Published: (2022-02-01)

How Are Adenosine and Adenosine A<sub>2A</sub> Receptors Involved in the Pathophysiology of Amyotrophic Lateral Sclerosis?
by: Akihisa Mori, et al.
Published: (2021-08-01)

Antiplatelet Effects of Selected Xanthine-Based Adenosine A<sub>2A</sub> and A<sub>2B</sub> Receptor Antagonists Determined in Rat Blood
by: Monika Kubacka, et al.
Published: (2023-08-01)

Adenosine A<sub>2A</sub>Receptors in Substance Use Disorders: A Focus on Cocaine
by: Karolina Wydra, et al.
Published: (2020-06-01)

A<sub>3</sub> Adenosine Receptor Antagonists with Nucleoside Structures and Their Anticancer Activity
by: Andrea Spinaci, et al.
Published: (2022-01-01)

Anti-Inflammatory Activities of 8-Benzylaminoxanthines Showing High Adenosine A<sub>2A</sub> and Dual A<sub>1</sub>/A<sub>2A</sub> Receptor Affinity
by: Michał Załuski, et al.
Published: (2023-09-01)

A<sub>2A</sub> Adenosine Receptor as a Potential Biomarker and a Possible Therapeutic Target in Alzheimer’s Disease
by: Stefania Gessi, et al.
Published: (2021-09-01)

Synthesis of Novel Fluorinated Xanthine Derivatives with High Adenosine A<sub>2B</sub> Receptor Binding Affinity
by: Marcel Lindemann, et al.
Published: (2021-05-01)

Involvement of P2Y<sub>1</sub>, P2Y<sub>6</sub>, A<sub>1</sub> and A<sub>2A</sub> Receptors in the Purinergic Inhibition of NMDA-Evoked Noradrenaline Release in the Rat Brain Cortex
by: Clara Quintas, et al.
Published: (2023-06-01)

Design and Synthesis of Novel Thiazolo[5,4-d]pyrimidine Derivatives with High Affinity for Both the Adenosine A<sub>1</sub> and A<sub>2A</sub> Receptors, and Efficacy in Animal Models of Depression
by: Flavia Varano, et al.
Published: (2021-07-01)

Expression and Impact of Adenosine A<sub>3</sub> Receptors on Calcium Homeostasis in Human Right Atrium
by: Carmen Tarifa, et al.
Published: (2023-02-01)

Adenosine A2A receptors and A2A receptor heteromers as key players in striatal function
by: Sergi eFerre, et al.
Published: (2011-06-01)

Activation of microglial cells triggers a release of brain-derived neurotrophic factor (BDNF) inducing their proliferation in an adenosine A<sub>2A</sub> receptor-dependent manner: A<sub>2A</sub> receptor blockade prevents BDNF release and proliferation of microglia
by: Gomes Catarina, et al.
Published: (2013-01-01)

Adenosine A<sub>2A</sub> receptor activation reduces recurrence and mortality from <it>Clostridium difficile</it> infection in mice following vancomycin treatment
by: Li Yuesheng, et al.
Published: (2012-12-01)

Development of <sup>18</sup>F-Labeled Radiotracers for PET Imaging of the Adenosine A<sub>2A</sub> Receptor: Synthesis, Radiolabeling and Preliminary Biological Evaluation
by: Thu Hang Lai, et al.
Published: (2021-02-01)

The Signaling Pathways Involved in the Anticonvulsive Effects of the Adenosine A<sub>1</sub> Receptor
by: Jeroen Spanoghe, et al.
Published: (2020-12-01)

Development of a Radiofluorinated Adenosine A<sub>2B</sub> Receptor Antagonist as Potential Ligand for PET Imaging
by: Marcel Lindemann, et al.
Published: (2020-04-01)

Adenosine A<sub>2A</sub> Receptor Up-Regulation Pre-Dates Deficits of Synaptic Plasticity and of Memory in Mice Exposed to Aβ<sub>1–42</sub> to Model Early Alzheimer’s Disease
by: Cátia R. Lopes, et al.
Published: (2023-07-01)

The Role of Lipids in Allosteric Modulation of Dopamine D<sub>2</sub> Receptor—In Silico Study
by: Justyna Żuk, et al.
Published: (2022-02-01)

Activation of the Rat α1β2ε GABA<sub>A</sub> Receptor by Orthosteric and Allosteric Agonists
by: Allison L. Germann, et al.
Published: (2022-06-01)

The Pharmacological Potential of Adenosine A<sub>2A</sub> Receptor Antagonists for Treating Parkinson’s Disease
by: Akihisa Mori, et al.
Published: (2022-04-01)

A Comparison in the Use of the Crystallographic Structure of the Human A<sub>1</sub> or the A<sub>2A</sub> Adenosine Receptors as a Template for the Construction of a Homology Model of the A<sub>3</sub> Subtype
by: Enrico Margiotta, et al.
Published: (2019-02-01)

Allosteric Modulators of Dopamine D<sub>2</sub> Receptors for Fine-Tuning of Dopaminergic Neurotransmission in CNS Diseases: Overview, Pharmacology, Structural Aspects and Synthesis
by: Agnieszka A. Kaczor, et al.
Published: (2022-12-01)

Molecular Biophysics of Class A G Protein Coupled Receptors–Lipids Interactome at a Glance—Highlights from the A<sub>2A</sub> Adenosine Receptor
by: Efpraxia Tzortzini, et al.
Published: (2023-06-01)

Adenosine A<sub>3</sub> Receptor (A<sub>3</sub>AR) Agonist for the Treatment of Bleomycin-Induced Lung Fibrosis in Mice
by: Silvia Sgambellone, et al.
Published: (2022-11-01)

Advantages in Wound Healing Process in Female Mice Require Upregulation A<sub>2A</sub>-Mediated Angiogenesis under the Stimulation of 17β-Estradiol
by: Felipe Troncoso, et al.
Published: (2020-09-01)

Pharmacology of Adenosine Receptors: Recent Advancements
by: Fabrizio Vincenzi, et al.
Published: (2023-09-01)

Piperazine- and Piperidine-Containing Thiazolo[5,4-<i>d</i>]pyrimidine Derivatives as New Potent and Selective Adenosine A<sub>2A</sub> Receptor Inverse Agonists
by: Flavia Varano, et al.
Published: (2020-07-01)

Adenosine Receptor Antagonists to Combat Cancer and to Boost Anti-Cancer Chemotherapy and Immunotherapy
by: Rafael Franco, et al.
Published: (2021-10-01)

Curcumin Stereoisomer, Cis-Trans Curcumin, as a Novel Ligand to A<sub>1</sub> and A<sub>3</sub> Adenosine Receptors
by: Luke J. Hamilton, et al.
Published: (2023-06-01)

PAC<sub>1</sub>, VPAC<sub>1</sub>, and VPAC<sub>2</sub> Receptor Expression in Rat and Human Trigeminal Ganglia: Characterization of PACAP-Responsive Receptor Antibodies
by: Zoe Tasma, et al.
Published: (2022-11-01)

Synthesis and Biological Evaluation of a Novel <sup>18</sup>F-Labeled Radiotracer for PET Imaging of the Adenosine A<sub>2A</sub> Receptor
by: Thu Hang Lai, et al.
Published: (2021-01-01)

Brain Iron Deficiency Changes the Stoichiometry of Adenosine Receptor Subtypes in Cortico-Striatal Terminals: Implications for Restless Legs Syndrome
by: Matilde S. Rodrigues, et al.
Published: (2022-02-01)

Radiosynthesis and In Vitro Evaluation of [<sup>11</sup>C]tozadenant as Adenosine A<sub>2A</sub> Receptor Radioligand
by: Swen Humpert, et al.
Published: (2024-02-01)

Adenosine Receptor Agonists Exhibit Anti-Platelet Effects and the Potential to Overcome Resistance to P2Y<sub>12</sub> Receptor Antagonists
by: Nina Wolska, et al.
Published: (2019-12-01)

Adenosine Receptors Profile in Fibromuscular Dysplasia
by: Claire Guiol, et al.
Published: (2022-11-01)

Caffeine for Prevention of Alzheimer’s Disease: Is the A<sub>2A</sub> Adenosine Receptor Its Target?
by: Stefania Merighi, et al.
Published: (2023-06-01)

Activation of Adenosine A<sub>3</sub> Receptor Inhibits Microglia Reactivity Elicited by Elevated Pressure
by: Joana Ferreira-Silva, et al.
Published: (2020-09-01)